Cellectis S A Revenue per Employee (CLLS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Cellectis S a   (NASDAQ: CLLS)
 

Cellectis S A 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 75.76% in the fourth quarter 2025, year on year to cumulative value of $90 million, Cellectis S A 's revenue per employee grew on a trailing twelve months basis to $ 391,590. The productivity of Cellectis S A 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 314 other companies have achieved higher revenue per employee. While Cellectis S A 's total ranking has deteriorated compared to the previous quarter from 0 to 2604. Cellectis S A has 229 employees.


What is Sales per Employee Ratio?







CLLS Revenue per Employee (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 75.76 % - 107.48 % - 23217.42 %
Sales per Employee (TTM) $ 391,590 254,279 254,279 216,445 216,445
CLLS's Total Ranking # 2604 # 0 # # #
Seq. Revenue Change - - - - -


Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 43
Healthcare Sector # 315
Overall Market # 2604

Revenue per Employee Statistics
High Average Low
$ 322,921 $ 182,650 $ 55,594
(Dec 31 2020)   (Dec 31 2018)



Financial Statements
Cellectis S A 's Revenue MRQ $ 73 Millions Visit CLLS's Income Statement
Cellectis S A 's Revenues TTM $ 90 Millions Visit CLLS's aggregate revenue growth
What are CLLS's Sales? Visit CLLS's Sales by Segment




Other Ratios
Cellectis S A 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CLLS's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CLLS's Competitors
Revenue per Employee for CLLS's Suppliers
Revenue per Employee for CLLS's Customers

You may also want to know
CLLS's Sales Growth Rates CLLS's Pe Price to earnings ratio CLLS's Receivables Turnover Ratio CLLS's Stock Quote
CLLS's Net Income Growth Rates CLLS's Ps Price to Sales ratio CLLS's Sales per Employee CLLS's Asset Turnover Ratio
CLLS's Net Margin CLLS's Pb Price to Book ratio CLLS's Financial Strength Ratios CLLS's Dividend Payout Ratio
Date modified: 2026-07-07T15:09:00+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Inspire Medical Systems inc   683,988.00 $ 911.756  Million 1,333 
Option Care Health Inc   683,389.18 $ 5,648.895  Million 8,266 
Elutia Inc   678,423.08 $ 17.639  Million 26 
Transmedics Group Inc   674,269.49 $ 605.494  Million 898 
Johnson and Johnson  668,984.38 $ 94,193.000  Million 140,800 
Organogenesis Holdings Inc   660,619.44 $ 564.169  Million 854 
Zoetis Inc   652,896.55 $ 9,467.000  Million 14,500 
Premier Air Charter Holdings Inc   650,561.39 $ 31.878  Million 49 
Veracyte Inc   648,386.75 $ 489.532  Million 755 
Cardiff Lexington Corporation  640,865.39 $ 11.536  Million 18 
Karyopharm Therapeutics Inc   640,644.74 $ 146.067  Million 228 
Organon and Co   622,800.00 $ 6,228.000  Million 10,000 
Biolife Solutions Inc   620,116.13 $ 96.118  Million 155 
Dyadic International Inc   618,069.00 $ 3.090  Million
Lexicon Pharmaceuticals Inc   614,851.85 $ 49.803  Million 81 
Bioventus Inc   603,026.60 $ 566.845  Million 940 
Intercure Ltd   600,444.44 $ 270.200  Million 450 
Bridgebio Pharma Inc   598,421.93 $ 502.076  Million 839 
Nature s Sunshine Products inc   595,191.07 $ 479.724  Million 806 
Intuitive Surgical Inc   591,287.23 $ 10,064.300  Million 17,021 
Mannkind Corporation  589,469.59 $ 348.966  Million 592 
Embecta Corp   583,459.46 $ 1,079.400  Million 1,850 
Syndax Pharmaceuticals Inc   578,362.42 $ 172.352  Million 298 
Xilio Therapeutics Inc   575,868.42 $ 43.766  Million 76 
Edap Tms Sa  574,777.44 $ 166.111  Million 289 
Koru Medical Systems Inc   563,388.58 $ 41.127  Million 73 
Phibro Animal Health Corporation  562,386.18 $ 1,465.016  Million 2,605 
Milestone Scientific Inc   560,505.13 $ 8.408  Million 15 
Enanta Pharmaceuticals Inc  558,166.67 $ 66.980  Million 120 
Nyxoah Sa  554,256.00 $ 11.085  Million 20 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.